Fertility Screening Panel
Fertility Screening blood test panel measures key reproductive hormones plus thyroid and metabolic markers to help you interpret cycle patterns and timing.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, not a single hormone test. A Fertility Screening panel bundles several blood tests that work best when you interpret them together—your ovarian reserve signals, ovulation-related hormones, thyroid function, and metabolic markers that can affect cycles and conception.
Do I need this panel?
You may consider a Fertility Screening panel if your cycles are irregular, you are tracking ovulation without clear patterns, or you are trying to understand whether hormones, thyroid function, or insulin resistance could be contributing to symptoms like acne, unwanted hair growth, heavy or skipped periods, or difficulty conceiving.
This panel can also be useful if you are planning pregnancy and want a baseline before you start trying, if you have a history of miscarriage, or if you are navigating perimenopause and want to separate “normal transition” changes from treatable issues like thyroid dysfunction or elevated prolactin.
Timing matters for fertility labs. Some markers are most informative early in the cycle (often cycle day 2–4), while others are best checked after ovulation (mid-luteal). If you are unsure when to test, this panel is a good starting point to discuss cycle timing and next steps with a clinician.
Your results can support clinician-directed care and shared decision-making, but they are not a diagnosis by themselves. The most helpful interpretation comes from combining your lab pattern with your cycle history, symptoms, medications, and (when relevant) ultrasound findings.
Reference ranges and optimal targets can vary by lab, cycle day, pregnancy status, and whether you use hormonal contraception or fertility medications.
Lab testing
Ready to order the Fertility Screening panel?
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a Fertility Screening lab panel and review your results in context. Instead of chasing individual tests across different orders, you get a bundled set of markers designed to be interpreted together.
Once your results are in, you can use PocketMD to ask questions like how your FSH and estradiol pattern fits with your AMH, whether your thyroid numbers are in a fertility-friendly range, or what follow-up testing makes sense based on your cycle timing.
If you are tracking PCOS, perimenopause changes, or fertility planning over time, repeating the same panel (with consistent cycle timing) can help you see trends rather than overreacting to a single month’s fluctuation.
- Order a multi-marker fertility lab panel in one checkout
- Plain-language interpretation support with PocketMD
- Useful for baseline testing and trend tracking over time
- Designed to be read as a pattern across hormones, thyroid, and metabolism
Key benefits of Fertility Screening
- Gives you a single, coordinated snapshot of fertility-relevant hormones rather than isolated one-off tests.
- Helps you interpret ovarian reserve signals (like AMH and day-3 FSH/estradiol patterns) in a more complete context.
- Supports ovulation and luteal-phase questions by pairing gonadotropins with progesterone-related timing decisions.
- Flags common “look-alikes” for cycle disruption, including thyroid imbalance and elevated prolactin.
- Adds metabolic context (glucose/insulin markers) that can matter for PCOS patterns and cycle regularity.
- Improves conversations with your clinician by turning symptoms and cycle tracking into measurable categories to act on.
- Makes retesting easier when you are monitoring changes after lifestyle shifts, supplements, or clinician-guided treatment.
What is the Fertility Screening panel?
The Fertility Screening panel is a bundled set of blood tests that look at multiple systems involved in reproductive function. Instead of focusing on one hormone, it checks a group of markers that often move together: ovarian reserve and follicle signaling, ovulation-related hormones, pituitary hormones that influence cycles, thyroid function (which can mimic or worsen fertility symptoms), and metabolic markers that can affect ovulation and androgen balance.
A key reason to use a panel is that single results can be misleading when taken out of context. For example, FSH (follicle-stimulating hormone) is often interpreted differently depending on estradiol (E2) at the same time, and thyroid-stimulating hormone (TSH) is more meaningful when paired with free T4 (thyroxine).
Your cycle day, whether you are postpartum, breastfeeding, approaching menopause, or using hormonal contraception can change what “normal” looks like. A panel approach helps you and your clinician decide what is a timing issue, what is a true imbalance, and what follow-up testing (if any) is worth adding.
What this panel can and cannot tell you
This panel can suggest patterns consistent with anovulation, diminished ovarian reserve signals, thyroid dysfunction, hyperprolactinemia, or insulin resistance. It cannot confirm tubal blockage, endometriosis, uterine structural issues, or sperm factors. Fertility is multi-factorial, so labs are one part of the picture.
Why timing and context matter
Some markers are “cycle-phase sensitive.” Day-3 style testing is commonly used for FSH, LH, and estradiol, while progesterone is usually interpreted in the mid-luteal phase (often about 7 days after ovulation). If your timing is off, a result may look abnormal even when physiology is normal for that phase.
How clinicians use patterns across markers
Clinicians often look for clusters: ovarian reserve markers together (AMH + FSH/E2), ovulatory function (LH patterns + progesterone timing), pituitary/thyroid contributors (prolactin + TSH/free T4), and metabolic drivers (glucose/insulin markers). The goal is to identify the most likely “rate-limiting step” for your cycle and fertility goals.
What do my panel results mean?
Patterns that can look “low” on this panel
A “low” pattern usually means one of the key fertility signals is underactive for the cycle phase you tested. Examples include low progesterone in the mid-luteal window (which can suggest you did not ovulate or that timing was off), low estradiol early in the cycle alongside higher FSH (which can be seen when the ovaries need more stimulation), or low free T4 with an inappropriately normal or high TSH (a thyroid pattern that can affect cycles). Low fasting insulin is not automatically a problem, but very low glucose or symptoms of hypoglycemia can complicate cycle tracking and energy balance. Because timing drives many “low” readings, the first step is confirming cycle day and whether you were using hormones or fertility medications.
Patterns that are often considered “optimal” for fertility planning
An “optimal” panel pattern is one where markers align with your cycle phase and your goals: ovarian reserve signals are reassuring for your age and context (for example, AMH and day-3 FSH/estradiol are not discordant), progesterone is appropriately elevated when measured in the right luteal window, prolactin is not elevated, and thyroid markers are in a range that supports regular cycles. Metabolic markers (glucose and insulin-related measures) are steady, which can support ovulation regularity—especially if you have a PCOS history. Even with an overall reassuring panel, you can still have fertility barriers outside bloodwork, so “optimal” labs are best viewed as removing common obstacles rather than guaranteeing outcomes.
Patterns that can look “high” on this panel
A “high” pattern often points to overstimulation signals, endocrine interference, or metabolic stress. Examples include higher FSH early in the cycle (especially if estradiol is also elevated, which can sometimes mask reserve-related interpretation), elevated prolactin (which can suppress ovulation), or higher TSH suggesting hypothyroidism physiology. Elevated fasting insulin or glucose-related markers can support an insulin-resistance pattern that commonly overlaps with irregular ovulation and PCOS features. Some “high” results are situational—stress, poor sleep, acute illness, and certain medications can shift pituitary and thyroid markers—so confirmation and repeat testing with consistent conditions is often more informative than reacting to a single draw.
Factors that influence Fertility Screening panel markers
Cycle timing is the biggest driver: the same hormone can be “low” on one day and “high” on another. Hormonal contraception, fertility medications (like gonadotropins, clomiphene, or letrozole), and recent pregnancy or breastfeeding can significantly change LH, FSH, estradiol, and prolactin. Thyroid markers can shift with iodine intake, biotin supplements (which can interfere with some immunoassays), and changes in thyroid medication dosing. Metabolic markers are influenced by fasting duration, recent exercise, alcohol intake, sleep, and acute illness. If your results do not match your symptoms or cycle tracking, the most common fixes are adjusting timing (day-3 vs mid-luteal), repeating the panel, or adding targeted follow-ups (such as androgens, thyroid antibodies, or ultrasound) based on your pattern.
What’s included in this panel
- Anti-Mullerian Hormone (Amh), Female
Frequently Asked Questions
Do I need to fast for the Fertility Screening panel?
Fasting is often helpful because this panel can include glucose and insulin markers that are easiest to interpret when you have not eaten for about 8–12 hours. Water is typically fine. If you cannot fast, you can still test, but tell your clinician (and note the timing of your last meal) so the metabolic portion is interpreted appropriately.
What cycle day should I test?
Many fertility hormones are commonly checked early in the cycle (often cycle day 2–4) for baseline interpretation, while progesterone is usually most meaningful in the mid-luteal phase (often about 7 days after ovulation). If you have irregular cycles or you are not sure you ovulated, your clinician may recommend a specific schedule or a repeat draw based on your tracking.
How do I interpret the panel if one marker is “normal” but another is abnormal?
That situation is common and is exactly why a panel can be more useful than a single test. Clinicians look for patterns and “discordance,” such as FSH interpreted alongside estradiol, or TSH interpreted alongside free T4. A single out-of-range value may reflect timing, medications, or lab variability, while a consistent cluster across related markers is more likely to be clinically meaningful.
Can this panel diagnose PCOS or early menopause?
This panel can support patterns that are consistent with PCOS (for example, ovulatory disruption plus insulin-resistance signals and androgen-related markers) or perimenopause/ovarian reserve concerns (for example, specific AMH and FSH/estradiol patterns). Diagnosis usually requires clinical criteria and sometimes ultrasound, plus ruling out other causes like thyroid dysfunction or elevated prolactin.
Should I stop supplements or medications before testing?
Do not stop prescription medications unless your clinician tells you to. Tell your clinician about hormonal contraception, fertility medications, thyroid medication, and any recent changes. Also mention biotin (often in hair/nail supplements), because it can interfere with some lab assays. If you are unsure what to pause, PocketMD can help you list what you take and what questions to ask before your draw.
Is it better to order a panel or individual fertility tests?
A panel is usually more efficient when you want a broad baseline because it reduces the chance of missing a key companion marker needed for interpretation (for example, pairing thyroid markers or reading FSH with estradiol). Individual tests can make sense when you are doing a focused follow-up (such as repeating progesterone with precise timing) or when a clinician is monitoring a specific treatment.
How often should I repeat this panel?
Repeat timing depends on your goal. If you are troubleshooting cycles, repeating after one to three cycles with consistent timing can clarify whether a finding is persistent. If you are monitoring a treatment change (thyroid dosing, prolactin treatment, metabolic interventions), your clinician may suggest retesting in 6–12 weeks for the affected markers, with the full panel repeated when a broader reassessment is needed.